Zobrazeno 1 - 10
of 2 344
pro vyhledávání: '"r-chop"'
Autor:
María Elena Cabrera, Camila Peña, Valeska Vega, Hernán Rojas, Alvaro Pizarro, Christine Rojas, Susana Calderon, Jacqueline Oliva, Cecilia Hales, Bernardita Rojas, Marvila Intriago, Marisa Capurro, M. Luisa Gonzalez, Jorge J. Castillo
Publikováno v:
Cancer Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
ABSTRACT Background Follicular lymphoma (FL) is the most common indolent non‐Hodgkin lymphoma (NHL) in the United States and Europe. However, data on FL from Latin America are scant. Aims This study aims at better understand the clinical features,
Externí odkaz:
https://doaj.org/article/28033eb3a9e54b2bbc55ef8f66d943ed
Autor:
A. S. Nozdricheva, I. B. Lysenko, N. K. Guskova, N. V. Nikolaeva, Ya. S. Gaysultanova, S. N. Dimitriadi, O. G. Ishonina
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 67-74 (2024)
Aim. To study the glomerular filtration rate (GFR) dynamics calculated by creatinine and cystatin C during induction immunochemotherapy in patients with newly diagnosed diffuse large B-cell lymphoma in order to objectify the method for estimation.Mat
Externí odkaz:
https://doaj.org/article/85e037c77f8b4d01b5ad06b26fa83ea9
Autor:
A. S. Nozdricheva, I. B. Lysenko, N. K. Guskova, M. A. Konovalchik, A. A. Maslov, E. V. Shalashnaya
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 78-83 (2023)
Aim. To study the glomerular filtration rate (GFR) dynamics during induction immunopolychemotherapy (PCT) in patients with newly diagnosed diffuse large B-cell lymphoma. Materials and methods. The study included 39 patients with newly diagnosed diffu
Externí odkaz:
https://doaj.org/article/deb99aa440264e94a6b82ef0d3368ab2
Challenges and perspectives of first-line therapy in patients with diffuse B-cell lymphoma: A review
Autor:
Lali G. Babicheva, Irina V. Poddubnaya
Publikováno v:
Современная онкология, Vol 25, Iss 2, Pp 178-184 (2023)
The neoplasm we refer to as diffuse large B-cell lymphoma (DLBCL) consists of many different subtypes that should not be subject to a single standardized treatment. Critical at the diagnostic stage is the identification of rare (510%) but extremely a
Externí odkaz:
https://doaj.org/article/2bf171915e834ae38c1d3b830267ed34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Real‐world data for lenalidomide maintenance in responding patients of diffuse large B‐cell lymphoma
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10553-10562 (2023)
Abstract Background Approximately 40% patients of diffuse large B‐cell lymphoma (DLBCL) would develop disease recurrence/progression after first‐line R‐CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) induction thera
Externí odkaz:
https://doaj.org/article/20d08e87f47c40c7a3baa3390feb5023
Autor:
Fatemeh Riasi, Sajjad Ataei Azimi, Abolghasem Allahyari, Mohammad Moeini Nodeh, Mohammad T. Shakeri, Mostafa Kamandi
Publikováno v:
Health Science Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)
Abstract Background and Aims The effect of stopping or reducing the dose of vincristine in diffuse large B‐cell lymphoma (DLBCL) on the outcome and prognosis of the disease is still in doubt. The present study aimed to investigate and compare the p
Externí odkaz:
https://doaj.org/article/41c546dcc7474e78b2409c2594287c9d
Autor:
Changjian Yan, Xue He, Ruiying Qi, Ling Cao, Siping Zheng, Chunyuan Huang, Ping Yang, Jing Wang, Mingxia Zhu, Shaoxiang Li, Gehong Dong, Hongmei Jing, Weilong Zhang, Xiaoni Liu
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective: Diffuse Large B-Cell Lymphoma (DLBCL) is a common and frequently occurring subtype of Non-Hodgkin Lymphoma (NHL). The effective treatment and prognosis of DLBCL are still urgently needed to be explored. This article aims to shed li
Externí odkaz:
https://doaj.org/article/4f19750882684d53a240e983589f5731
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas
Autor:
Alice Turdo, Miriam Gaggianesi, Caterina D’Accardo, Gaetana Porcelli, Sebastiano Di Bella, Dario Cricchio, Irene Pillitteri, Rossana Porcasi, Melania Lo Iacono, Francesco Verona, Chiara Modica, Narges Roozafzay, Ada Maria Florena, Giorgio Stassi, Salvatrice Mancuso, Matilde Todaro
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDiffuse large B-cell lymphoma (DLBCL) is a hematological malignancy representing one-third of non-Hodgkin’s lymphoma cases. Notwithstanding immunotherapy in combination with chemotherapy (R-CHOP) is an effective therapeutic approach for D
Externí odkaz:
https://doaj.org/article/b198c3f32aad41e698a82358a2a2963c
Autor:
Limei Zhang, He Huang, Zhao Wang, Xiaojie Fang, Huangming Hong, Yungchang Chen, Quanguang Ren, Yuyi Yao, Zegeng Chen, Fei Pan, Xiaoqian Li, Meiting Chen, Tongyu Lin
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6924-6934 (2023)
Abstract Background Stomach hemorrhage and perforation are very severe and common complications in patients with primary gastric diffuse large B‐cell lymphoma (PG‐DLBCL) during treatment with immunochemotherapy. However, no relevant clinical stud
Externí odkaz:
https://doaj.org/article/fe6b38ff661b4e339c71b5f8502e671e